BPMC
Blueprint Medicines Corp
Price:  
128.25 
USD
Volume:  
5,148,158.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC EV/EBITDA

-122.6%
Upside

As of 2025-06-17, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,547.89 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 10.5x 9.3x
Forward P/E multiples 9.3x - 11.3x 11.1x
Fair Price (26.81) - (29.84) (29.01)
Upside -120.9% - -123.3% -122.6%
128.25 USD
Stock Price
(29.01) USD
Fair Price

BPMC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-16 -54.23
2025-06-13 -54.11
2025-06-12 -54.21
2025-06-11 -54.11
2025-06-10 -54.11
2025-06-09 -54.11
2025-06-06 -54.06
2025-06-05 -54.09
2025-06-04 -54.17
2025-06-03 -53.96
2025-06-02 -54.04
2025-05-30 -43.21
2025-05-29 -43.91
2025-05-28 -40.73
2025-05-27 -42.68
2025-05-23 -43.27
2025-05-22 -42.79
2025-05-21 -43.27
2025-05-20 -43.88
2025-05-19 -43.15
2025-05-16 -43.35
2025-05-15 -42.45
2025-05-14 -41.63
2025-05-13 -42.41
2025-05-12 -42.78
2025-05-09 -41.50
2025-05-08 -42.15
2025-05-07 -42.57
2025-05-06 -42.31
2025-05-05 -43.41
2025-05-02 -44.56
2025-05-01 -42.35
2025-04-30 -38.35
2025-04-29 -37.93
2025-04-28 -37.95
2025-04-25 -37.60
2025-04-24 -36.96
2025-04-23 -36.84
2025-04-22 -35.86
2025-04-21 -36.17
2025-04-17 -36.38
2025-04-16 -35.32
2025-04-15 -35.05
2025-04-14 -35.50
2025-04-11 -34.80
2025-04-10 -34.57
2025-04-09 -35.30
2025-04-08 -34.14
2025-04-07 -34.54
2025-04-04 -35.15